← FDA Drug Approvals (Drugs@FDA)

ACUVUE THERAVISION WITH KETOTIFEN

NDA · New Drug Application · Sponsor: JOHNSON JOHNSON VISN · Approved 2022-02-25

Drug application

FDA Application #

NDA022388

Application type

New Drug Application

Brand name

ACUVUE THERAVISION WITH KETOTIFEN

Generic name

Ketotifen Fumarate

Active ingredients

KETOTIFEN FUMARATE

Dosage form

DRUG-ELUTING CONTACT LENS

Route

OPHTHALMIC

Marketing status

Discontinued

Sponsor

JOHNSON JOHNSON VISN

First approval

2022-02-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown